These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8991040)

  • 21. Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
    Olin DA; Urdaneta F; Lobato EB
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):707-9. PubMed ID: 11139115
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of heparin-induced thrombocytopenia.
    Greinacher A
    Thromb Haemost; 1999 Aug; 82(2):457-67. PubMed ID: 10605737
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bounderies of the authorization to market and the therapeutic impass].
    Samama CM
    Ann Fr Anesth Reanim; 2001 Jun; 20(6):507-8. PubMed ID: 11471497
    [No Abstract]   [Full Text] [Related]  

  • 24. Immediate use of anticoagulants may not improve stroke outcomes.
    Am J Health Syst Pharm; 1998 Jun; 55(12):1240. PubMed ID: 9640462
    [No Abstract]   [Full Text] [Related]  

  • 25. Danaparoid in the prevention of ischemic stroke in paroxysmal nocturnal hemoglobinuria.
    Zyss J; Cakmak S; Derex L; Michallet M; Nighoghossian N
    Cerebrovasc Dis; 2007; 23(5-6):462-3. PubMed ID: 17435387
    [No Abstract]   [Full Text] [Related]  

  • 26. Ardeparin and danaparoid for prevention of deep vein thrombosis.
    Med Lett Drugs Ther; 1997 Oct; 39(1011):94-5. PubMed ID: 9379998
    [No Abstract]   [Full Text] [Related]  

  • 27. [Danaparoid for anticoagulation with Cell Saver 5. Answer to the letter of A. Lorentz].
    von Lüpke U
    Anaesthesist; 2001 Oct; 50(10):793. PubMed ID: 11702331
    [No Abstract]   [Full Text] [Related]  

  • 28. Safe anticoagulation with danaparoid in pregnancy and lactation.
    Schindewolf M; Mosch G; Bauersachs RM; Lindhoff-Last E
    Thromb Haemost; 2004 Jul; 92(1):211. PubMed ID: 15213864
    [No Abstract]   [Full Text] [Related]  

  • 29. Extracorporeal membrane oxygenation with danaparoid sodium after massive pulmonary embolism.
    Bauer C; Vichova Z; Ffrench P; Hercule C; Jegaden O; Bastien O; Lehot JJ
    Anesth Analg; 2008 Apr; 106(4):1101-3, table of contents. PubMed ID: 18349178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin-induced thrombocytopenia in hemodialysis patients.
    Brouwer DJ; Peterson P
    Nephrol Nurs J; 2000 Apr; 27(2):240-1, 213. PubMed ID: 11111553
    [No Abstract]   [Full Text] [Related]  

  • 31. [Sinus thrombosis in heparin-induced thrombocytopenia type II].
    Schill D
    Med Monatsschr Pharm; 2005 Jul; 28(7):253-4. PubMed ID: 16038130
    [No Abstract]   [Full Text] [Related]  

  • 32. Recurrence of venous thromboembolism after treatment with unfractionated heparin.
    Sutton SK
    Ann Intern Med; 1996 Mar; 124(5):532. PubMed ID: 8602716
    [No Abstract]   [Full Text] [Related]  

  • 33. Classification of subtypes of ischemic stroke: history of the trial of org 10172 in acute stroke treatment classification.
    Adams HP; Biller J
    Stroke; 2015 May; 46(5):e114-7. PubMed ID: 25813192
    [No Abstract]   [Full Text] [Related]  

  • 34. Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses.
    Tardy B; Tardy-Poncet B; Viallon A; Piot M; Mazet E
    Thromb Haemost; 1998 Sep; 80(3):530. PubMed ID: 9759647
    [No Abstract]   [Full Text] [Related]  

  • 35. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
    Westphal K; Martens S; Strouhal U; Matheis G; Lindhoff-Last E; Wimmer-Greinecker G; Lischke V
    Thorac Cardiovasc Surg; 1997 Dec; 45(6):318-20. PubMed ID: 9477469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of Organon, a synthetic heparinoid, in two cardiopulmonary bypass procedures in the same patient sensitive to heparin].
    Pineau E; Le Bret E; Folliguet T; Saint Maurice OS; Carbognani D; Laborde F
    Arch Mal Coeur Vaiss; 2001 Feb; 94(2):144-7. PubMed ID: 11265553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Heparin-induced thrombocytopenia].
    Depasse F; Samama MM
    Ann Biol Clin (Paris); 2000; 58(3):317-26. PubMed ID: 10846236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Danaparoid sodium (Orgaran) in four children with heparin-induced thrombocytopenia type II.
    Zöhrer' B; Zenz W; Rettenbacher A; Covi P; Kurnik K; Kroll H; Grubbauer HM; Muntean W
    Acta Paediatr; 2001 Jul; 90(7):765-71. PubMed ID: 11519979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thrombocytopenia due to heparin therapy. Use of danaparoid (Orgaran), 13 monocentric cases under authorization of temporary prescription (ATU)].
    Gindre L; de Maistre E; Perrin A; Lecompte T; Hoffman MA
    Therapie; 1997; 52(6):591-7. PubMed ID: 9734113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiopulmonary bypass using lomoparan: monitoring of anticoagulation using anti-Xa levels and thromboelastography.
    Sharma S; Newman M; Gibbs N; Parkinson G
    Aust N Z J Surg; 1997 Jun; 67(6):392-4. PubMed ID: 9193279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.